Literature DB >> 8404128

The use of thoracoscopy in the treatment of iatrogenic esophageal perforations.

T Kiel1, G Ferzli, J McGinn.   

Abstract

Treatment options for patients with iatrogenic esophageal perforations are multiple and remain a source of controversy. Therapeutic options range from conservative, non-operative treatment to esophageal exclusion or esophagectomy. We present herein what we believe to be the first described repair of an esophageal perforation using thoracoscopic surgical techniques. We believe this approach offers several advantages over open thoracic surgery and has a role in minimizing postoperative morbidity in an already potentially life-threatening condition.

Entities:  

Mesh:

Year:  1993        PMID: 8404128     DOI: 10.1378/chest.103.6.1905

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Adequate debridement and drainage of the mediastinum using open thoracotomy or video-assisted thoracoscopic surgery for Boerhaave's syndrome.

Authors:  Jan Willem Haveman; Vincent B Nieuwenhuijs; Jeroen P Muller Kobold; Gooitzen M van Dam; John Th Plukker; H Sijbrand Hofker
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

2.  Transabdominal approach assisted by thoracoscopic drainage for lower esophageal perforation.

Authors:  Harufumi Maki; Masaki Azuma; Hitoshi Kanamaru; Motohiro Nishiyama; Kazuya Okamoto; Takahiro Shimamura; Kennoki Kyo; Atsushi Maema; Toshio Nakamura; Motoaki Shirakawa; Hidetaro Yokoyama
Journal:  J Surg Case Rep       Date:  2015-12-01

Review 3.  Management of Esophageal Perforation in Adults.

Authors:  Lileswar Kaman; Javid Iqbal; Byju Kundil; Rakesh Kochhar
Journal:  Gastroenterology Res       Date:  2010-11-20

Review 4.  The insidious presentation and challenging management of esophageal perforation following diagnostic and therapeutic interventions.

Authors:  Savvas Lampridis; Sofoklis Mitsos; Martin Hayward; David Lawrence; Nikolaos Panagiotopoulos
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.